Literature DB >> 24662050

Phosphoinositide-dependent kinase 1 and mTORC2 synergistically maintain postnatal heart growth and heart function in mice.

Xia Zhao1, Shuangshuang Lu, Junwei Nie, Xiaoshan Hu, Wen Luo, Xiangqi Wu, Hailang Liu, Qiuting Feng, Zai Chang, Yaoqiu Liu, Yunshan Cao, Haixiang Sun, Xinli Li, Yali Hu, Zhongzhou Yang.   

Abstract

The protein kinase Akt plays a critical role in heart function and is activated by phosphorylation of threonine 308 (T308) and serine 473 (S473). While phosphoinositide-dependent kinase 1 (PDK1) is responsible for Akt T308 phosphorylation, the identities of the kinases for Akt S473 phosphorylation in the heart remain controversial. Here, we disrupted mTOR complex 2 (mTORC2) through deletion of Rictor in the heart and found normal heart growth and function. Rictor deletion caused significant reduction of Akt S473 phosphorylation but enhanced Akt T308 phosphorylation, suggesting that a high level of Akt T308 phosphorylation maintains Akt activity and heart function. Deletion of Pdk1 in the heart caused significantly enhanced Akt S473 phosphorylation that was suppressed by removal of Rictor, leading to worsened dilated cardiomyopathy (DCM) and accelerated heart failure in Pdk1-deficient mice. In addition, we found that increasing Akt S473 phosphorylation through deletion of Pten or chemical inhibition of PTEN reversed DCM and heart failure in Pdk1-deficient mice. Investigation of heart samples from human DCM patients revealed changes similar to those in the mouse models. These results demonstrated that PDK1 and mTORC2 synergistically promote postnatal heart growth and maintain heart function in postnatal mice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662050      PMCID: PMC4019065          DOI: 10.1128/MCB.00144-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

Review 1.  Sizing up the heart: development redux in disease.

Authors:  Eric N Olson; Michael D Schneider
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

2.  Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure.

Authors:  S Haq; G Choukroun; H Lim; K M Tymitz; F del Monte; J Gwathmey; L Grazette; A Michael; R Hajjar; T Force; J D Molkentin
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

3.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

4.  Cardiovascular science: opportunities for translating research into improved care.

Authors:  Eugene Braunwald
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

5.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.

Authors:  M R Williams; J S Arthur; A Balendran; J van der Kaay; V Poli; P Cohen; D R Alessi
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

Review 6.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

7.  S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt.

Authors:  Ruomin Di; Xiangqi Wu; Zai Chang; Xia Zhao; Qiuting Feng; Shuangshuang Lu; Qing Luan; Brian A Hemmings; Xinli Li; Zhongzhou Yang
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

Review 8.  Genetic mutations and mechanisms in dilated cardiomyopathy.

Authors:  Elizabeth M McNally; Jessica R Golbus; Megan J Puckelwartz
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

9.  Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.

Authors:  Ray E Hershberger; Ana Morales; Jill D Siegfried
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822

10.  Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth.

Authors:  Yi Zhu; Karla M P Pires; Kevin J Whitehead; Curtis D Olsen; Benjamin Wayment; Yi Cheng Zhang; Heiko Bugger; Olesya Ilkun; Sheldon E Litwin; George Thomas; Sara C Kozma; E Dale Abel
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more
  13 in total

Review 1.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

2.  Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells in vitro.

Authors:  Bei Zheng; Jiadan Wang; Leilei Tang; Chao Tan; Zhe Zhao; Yi Xiao; Renshan Ge; Danyan Zhu
Journal:  Int J Biol Sci       Date:  2017-01-15       Impact factor: 6.580

3.  The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.

Authors:  Ning Zhou; Ben Ma; Shaunrick Stoll; Tristan T Hays; Hongyu Qiu
Journal:  Aging Cell       Date:  2017-08-11       Impact factor: 9.304

4.  Full Activation of Kinase Protein Kinase B by Phosphoinositide-Dependent Protein Kinase-1 and Mammalian Target of Rapamycin Complex 2 Is Required for Early Natural Killer Cell Development and Survival.

Authors:  Junming He; Jun Zhao; Yuhe Quan; Xinlei Hou; Meixiang Yang; Zhongjun Dong
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

5.  Rictor/mTORC2 involves mitochondrial function in ES cells derived cardiomyocytes via mitochondrial Connexin 43.

Authors:  Jia-Dan Wang; Ying Shao; Dan Liu; Nuo-Ya Liu; Dan-Yan Zhu
Journal:  Acta Pharmacol Sin       Date:  2021-02-05       Impact factor: 7.169

6.  [Rictor regulates mitochondrial calcium signaling in mouse embryo stem cell-derived cardiomyocytes].

Authors:  Ying Shao; Jiadan Wang; Danyan Zhu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25

7.  Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo.

Authors:  Maximilian Kleinert; Lykke Sylow; Daniel J Fazakerley; James R Krycer; Kristen C Thomas; Anne-Julie Oxbøll; Andreas B Jordy; Thomas E Jensen; Guang Yang; Peter Schjerling; Bente Kiens; David E James; Markus A Ruegg; Erik A Richter
Journal:  Mol Metab       Date:  2014-06-27       Impact factor: 7.422

Review 8.  Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.

Authors:  Arun Samidurai; Rakesh C Kukreja; Anindita Das
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

9.  The G4 resolvase RHAU modulates mRNA translation and stability to sustain postnatal heart function and regeneration.

Authors:  Mingyang Jiang; Han Hu; Ke Zhao; Ruomin Di; Xinyi Huang; Yingchao Shi; Yunyun Yue; Junwei Nie; Shan Yu; Wengong Wang; Zhongzhou Yang
Journal:  J Biol Chem       Date:  2020-11-23       Impact factor: 5.157

Review 10.  Role of PTEN-less in cardiac injury, hypertrophy and regeneration.

Authors:  Tian Liang; Feng Gao; Jinghai Chen
Journal:  Cell Regen       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.